The Pharmaceutical Research and Manufacturers of America (PhRMA)
released today updated Guiding Principles: Direct to Consumer
Advertisements About Prescription Medicines (Guiding
Principles), which will be effective April 15, 2019. These Guiding
Principles replace the prior version.
Revisions to the Guiding Principles include a new principle
19 that all product-related direct to consumer (DTC) television
advertising include direction where patients can find information
about the cost of the medicine, including the list price and
average, estimated or typical patient out-of-pocket costs. PhRMA
also provided three new FAQs related to principle 19.
Life sciences companies should carefully consider the revisions
to the PhRMA Guiding Principles, and make appropriate adjustments
to policies, procedures and practices related to DTC
advertising.